(Press-News.org) Doctors often prescribe radiation along with surgery to treat a brain tumor called meningioma that originates in the protective membranes surrounding the brain. But side effects from radiation can be serious, including memory loss and cognitive decline, so it’s important to know which patients really need it.
Now, researchers at UC San Francisco and Northwestern Medicine, in collaboration with 10 other medical centers, have found a highly accurate way to predict the best treatment for patients based on patterns of gene expression – which genes are turned on and off – in their tumors.
Screening tumors using this new approach could change the course of treatment for nearly 1 in 3 people with meningioma, the most common form of brain tumor diagnosed in 42,000 Americans each year. Unlike other brain tumors, meningiomas occur most often in female, Black and elderly patients.
In a paper appearing Nov. 9, 2023 in Nature Medicine, the team concluded that just 1 in 5 patients with low-grade tumors (those less likely to regrow) may need radiation, while around 2 in 5 with higher-grade tumors may be better off without radiation, based on the results of the new gene-expression test.
“There’s been a lot of controversy in the field in terms of who should receive radiotherapy and who shouldn't,” said David Raleigh, MD, PhD, a radiation oncologist in the UCSF Brain Tumor Center and a senior author of the study, along with Stephen Magill, MD, PhD, assistant professor of neurological surgery at Northwestern University Feinberg School of Medicine. “Our biomarker takes the guessing game out of this and shows us which patients are likely to benefit from radiotherapy and which may get toxicity and possibly no benefit from radiation.”
From microscopes to molecules
Because meningiomas grow slowly, a patient may be unaware of their tumor until they start to experience neurological symptoms like numbness, vision loss or personality changes. There are no pharmaceutical treatments, so doctors rely on surgery to remove the tumor and radiation to prevent it from growing back. Doctors treat these tumors based on guidance from the World Health Organization, which stages them according to severity.
Pathologists currently classify meningiomas by looking at them under a microscope for features that indicate whether they may grow back, a system that is very good but not perfect. Patients with Grade 1 tumors don’t usually receive radiation treatment if their tumors can be removed completely during surgery. Yet approximately 20% of the time, the tumors recur. Those with Grade 2 and 3 tumors, which are much more aggressive and more likely to grow back after surgery, are often treated with radiation after surgery. It has been unclear how many of these patients, particularly those with Grade 2 tumors, actually need radiation treatment.
Raleigh, along with Magill and lead author William Chen, MD, decided to look at classifying tumors according to which of their genes are turned on and off, thereby offering clues to how aggressive they might be.
“Gene-expression tests like this, that analyze a small number of genes at a time, are widely available for breast, prostate and some other cancers, and they've proven to be a very accurate and inexpensive alternative to other types of tests,” said Chen.
How to turn guesses into answers
Raleigh and Chen and their multidisciplinary team suspected that gene expression could more accurately point out the patients who would be helped by radiotherapy. Using samples from 1,856 meningioma patients at 12 medical centers in the U.S., Europe and Hong Kong, Raleigh’s team came up with a set of 34 genes whose gene expression patterns had the potential to predict whether a tumor would return.
One-fifth of the Grade 1 tumors – the same number that grow back after surgery – expressed the patterns that Raleigh’s team found could predict a tumor’s regrowth. This fraction of patients may benefit from radiation. The researchers also found that two-fifths of patients with Grade 2 and 3 tumors did not have a recurrence, and this, too, could be predicted by the tumor’s gene expression.
“When to proceed with additional surgery, radiotherapy or simply to observe a small residual meningioma is not always clear,” said Magill. “This test adds information that can let us tailor our surgical and radiation approach to provide the best outcome for each patient and maximize both quality and quantity of life.”
The team’s next step is to test the approach in two clinical trials currently being developed.
Authors: For additional authors, please see the study.
Funding: This study was supported by NIH grants (P50 CA097257, P50 CA221747, U01 CA180868, U10 CA180822, R01 CA262311, F32 CA213944, F30 CA246808, T32 GM007618) and philanthropy. For a full list of funders, please see the study.
END
Can gene expression predict if a brain tumor is likely to grow back?
New test could change treatment for 1 in 3 patients with meningioma
2023-11-15
ELSE PRESS RELEASES FROM THIS DATE:
Microbes could help reduce the need for chemical fertilizers
2023-11-15
Production of chemical fertilizers accounts for about 1.5 percent of the world’s greenhouse gas emissions. MIT chemists hope to help reduce that carbon footprint by replacing some chemical fertilizer with a more sustainable source — bacteria.
Bacteria that can convert nitrogen gas to ammonia could not only provide nutrients that plants need, but also help regenerate soil and protect plants from pests. However, these bacteria are sensitive to heat and humidity, so it’s difficult to scale up their manufacture and ship them to farms.
To overcome that obstacle, ...
Virginia Tech and Arizona State researchers discover way to boost shelter dog adoptions
2023-11-15
After a long day at work, you open the door to the place you call home. A chorus of furry happiness rushes toward you, the sound of unconditional canine love. With your return, your dog's world is whole.
Virginia Tech and Arizona State University researchers are working to help more shelter dogs experience this kind of love, safety, and happiness in an adoptive home.
The research team in Virginia Tech's College of Agriculture and Life Sciences found that implementing shorter-term fostering programs ...
Astronomers discover signs of life in a star’s explosive death
2023-11-15
**Strictly embargoed until 16:00 (BST) Wednesday 15 November 2023**
Scientists have observed a series of bright, brief flashes occurring months after a stellar explosion, known as a luminous fast blue optical transient, or LFBOT
The sighting of the never before seen flashes were made possible thanks to the University of Sheffield’s ULTRASPEC camera, mounted on the Thai National Telescope
Since their discovery in 2018, astronomers have speculated about what might drive such extreme explosions
Astrophysicists have settled the debate over the nature of a rare ...
Fourth dose of COVID vaccine boosts protection in patients with rheumatic disease
2023-11-15
Patients with autoimmune rheumatic diseases, which include rheumatoid arthritis and other chronic disorders that cause inflammation, are at increased risk of SARS-CoV-2 infection, as well as death due to severe COVID-19. Many patients receive disease-modifying antirheumatic drugs (DMARDs) to treat these conditions, but this treatment has been associated with a blunted response to COVID-19 vaccines. The U.S. Centers for Disease Control and Prevention recommends that patients receiving DMARDs receive a fourth ...
MD Anderson research highlights for November 15, 2023
2023-11-15
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Recent developments at MD Anderson include insights into the role of RNA-binding proteins in DNA damage repair, the functional role of a hidden microprotein in regulating colorectal cancer gene expression, immunotherapy combinations in gynecologic cancers, the benefits of preventive exercise in protecting ...
Exposure to air pollution in utero may affect reproductive system development
2023-11-15
From invisible wafts of diesel exhaust to sun-choking plumes of orange smoke, air pollution is known to damage respiratory well-being. Now, research from Rutgers suggests another reason to hold our breath: Polluted air also may hurt reproductive health.
In a study of air pollution data in relation to markers of reproductive development in infancy, Rutgers researchers found certain pollutants may negatively alter anogenital distance, a measure of prenatal exposure to hormones.
“These findings suggest air ...
Novel C. diff structures are required for infection, offer new therapeutic targets
2023-11-15
Iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — could offer new targets for antibacterial drugs to combat the pathogen.
A team of Vanderbilt researchers discovered that C. diff (Clostridioides difficile) produces the spheres, called ferrosomes, and that these structures are important for infection in an animal model. The findings, reported Nov. 15 in the journal Nature, are also a rare demonstration of a membrane-bound structure inside a pathogenic bacterium.
Bacteria have long been thought not to contain organelles ...
UK diabetes prevention program may have global impact
2023-11-15
A nationwide programme to reduce the risk of developing diabetes in the UK is proven beyond reasonable doubt to work, a new study reveals.
The positive effects observed in the NHS Diabetes Prevention Programme – the largest such project in the world helping people across the UK to lose weight and control their blood sugar levels – may have relevance globally for tackling the diabetes epidemic.
The Diabetes Prevention Programme (NHS DPP) in England referred adults with high risk of developing diabetes to lifestyle counselling for losing weight, encouraging physical activity, and other ...
James Webb Space Telescope detects water vapor, sulfur dioxide and sand clouds in the atmosphere of a nearby exoplanet
2023-11-15
A team of European astronomers, co-led by researchers from the Institute of Astronomy, KU Leuven, used recent observations made with the James Webb Space Telescope to study the atmosphere of the nearby exoplanet WASP-107b. Peering deep into the fluffy atmosphere of WASP-107b they discovered not only water vapour and sulfur dioxide, but even silicate sand clouds. These particles reside within a dynamic atmosphere that exhibits vigorous transport of material.
Astronomers worldwide are harnessing the advanced capabilities of the Mid-Infrared Instrument (MIRI) aboard the James Webb Space Telescope (JWST) to conduct groundbreaking observations of exoplanets – planets orbiting stars ...
New laser setup probes metamaterial structures with ultrafast pulses
2023-11-15
Metamaterials are products of engineering wizardry. They are made from everyday polymers, ceramics, and metals. And when constructed precisely at the microscale, in intricate architectures, these ordinary materials can take on extraordinary properties.
With the help of computer simulations, engineers can play with any combination of microstructures to see how certain materials can transform, for instance, into sound-focusing acoustic lenses or lightweight, bulletproof films.
But simulations can only take a design so far. To know for sure whether a metamaterial will stand up to expectation, physically testing them is a must. But there’s been no reliable way to push and pull ...
LAST 30 PRESS RELEASES:
Post-LLM era: New horizons for AI with knowledge, collaboration, and co-evolution
“Sloshing” from celestial collisions solves mystery of how galactic clusters stay hot
Children poisoned by the synthetic opioid, fentanyl, has risen in the U.S. – eight years of national data shows
USC researchers observe mice may have a form of first aid
VUMC to develop AI technology for therapeutic antibody discovery
Unlocking the hidden proteome: The role of coding circular RNA in cancer
Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC
Study reveals widening heart disease disparities in the US
The role of ubiquitination in cancer stem cell regulation
New insights into LSD1: a key regulator in disease pathogenesis
Vanderbilt lung transplant establishes new record
Revolutionizing cancer treatment: targeting EZH2 for a new era of precision medicine
Metasurface technology offers a compact way to generate multiphoton entanglement
Effort seeks to increase cancer-gene testing in primary care
Acoustofluidics-based method facilitates intracellular nanoparticle delivery
Sulfur bacteria team up to break down organic substances in the seabed
Stretching spider silk makes it stronger
Earth's orbital rhythms link timing of giant eruptions and climate change
Ammonia build-up kills liver cells but can be prevented using existing drug
New technical guidelines pave the way for widespread adoption of methane-reducing feed additives in dairy and livestock
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
New study finds that tooth size in Otaria byronia reflects historical shifts in population abundance
nTIDE March 2025 Jobs Report: Employment rate for people with disabilities holds steady at new plateau, despite February dip
Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure
Fluoride in drinking water is associated with impaired childhood cognition
New composite structure boosts polypropylene’s low-temperature toughness
While most Americans strongly support civics education in schools, partisan divide on DEI policies and free speech on college campuses remains
Revolutionizing surface science: Visualization of local dielectric properties of surfaces
LearningEMS: A new framework for electric vehicle energy management
Nearly half of popular tropical plant group related to birds-of-paradise and bananas are threatened with extinction
[Press-News.org] Can gene expression predict if a brain tumor is likely to grow back?New test could change treatment for 1 in 3 patients with meningioma